Clinical Trials List
Protocol Number3151A2-334-AP
2007-01-01 - 2008-06-30
Phase III
Terminated1
-
Trial Applicant
Wyeth-Ayerst (Asia) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
450 participants
